Form 4: Boston Scientific EVP Joseph Fitzgerald Reports Stock Transactions
SEC Form 4 Filing
Executive Vice President of Boston Scientific, Joseph Michael Fitzgerald, reports the acquisition and disposal of company stock and restricted stock units.
Summary
- Joseph Michael Fitzgerald, an EVP at Boston Scientific, filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
- On February 12, 2025, Fitzgerald acquired 3,462 shares of common stock upon the vesting of restricted stock units.
- He also disposed of 1,579 shares to cover tax obligations at a price of $105.77 per share.
- Following these transactions, Fitzgerald directly owns 174,746 shares of Boston Scientific common stock.
- He also indirectly owns 4,894 shares through his child, but disclaims beneficial ownership of these shares.
- Fitzgerald also holds 10,386 restricted stock units, which will vest in four equal annual installments starting February 12, 2025.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about ownership changes.
Future Outlook
Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant.
Industry Context
Form 4 filings are routine disclosures required by the SEC for corporate insiders, providing transparency into their trading activities and ownership positions in their companies. This filing indicates the executive's ongoing investment in the company.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the overall effect is likely minimal.
Key Dates
| Date | Description |
|---|---|
| 02/12/2025 | Date of stock acquisition and disposal, and vesting of restricted stock units. |
| 02/12/2025 | First anniversary of the date of grant for restricted stock units, with shares issued in four equal annual installments. |
| 02/12/2028 | Expiration date of the restricted stock units. |
| 02/14/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.